Arthritis; Arthritis, Rheumatoid |
Phase 3 |
ClinicalTrials |
Arthritis; Arthritis, Rheumatoid |
Phase 2 |
ClinicalTrials |
Arthritis; Arthritis, Rheumatoid |
Phase 2 |
ClinicalTrials |
Arthritis; Arthritis, Rheumatoid |
Phase 2 |
ClinicalTrials |
Autoimmune Diseases; Connective Tissue Diseases; Lupus Erythematosus, Systemic |
Phase 3 |
ClinicalTrials |
Autoimmune Diseases; Connective Tissue Diseases; Lupus Erythematosus, Systemic |
Phase 3 |
ClinicalTrials |
Arthritis; Arthritis, Rheumatoid |
Phase 3 |
ClinicalTrials |
Arthritis; Arthritis, Rheumatoid |
Phase 2 |
ClinicalTrials |
Arthritis; Arthritis, Rheumatoid |
Phase 1 |
ClinicalTrials |
Arthritis; Arthritis, Rheumatoid |
Phase 3 |
ClinicalTrials |
Multiple Myeloma; Neoplasms, Plasma Cell |
Phase 1 |
ClinicalTrials |
Kidney Diseases; Kidney Failure, Chronic; Renal Insufficiency |
Phase 2 |
ClinicalTrials |
Arthritis; Arthritis, Rheumatoid |
Phase 2 |
ClinicalTrials |
Autoimmune Diseases; Connective Tissue Diseases; Lupus Erythematosus, Systemic |
Phase 3 |
ClinicalTrials |
Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Sclerosis |
Phase 2 |
ClinicalTrials |
Arthritis; Arthritis, Rheumatoid |
Phase 3 |
ClinicalTrials |